VitalConnect Announces Closure of $39 Million Round of Growth Financing

Series E Financing led by EW Healthcare Partners with Robert S. White to Join Board

San Jose, Calif. — January 10, 2022 —VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the completion of a $39 million round of financing, funded by EW Healthcare Partners in addition to other new and existing VitalConnect investors. Additionally, the company announced that Robert S. White, Operating Partner at EW Healthcare Partners, has joined its Board of Directors.

The latest round of investment will go toward expanding the commercial team, scaling operations, and the development of new products, all in an effort to drive top-line growth and continue bringing the best technology to patients and providers.

“This latest round of financing will help VitalConnect continue our upward trajectory in Cardiac Monitoring spaces,” said Peter Van Haur, CEO, VitalConnect. “We’ve experienced significant growth and rapid physician adoption over the past year and with the help of our investors we will continue to bring customers the most comprehensive, remote patient monitoring platform on the market.”

Additionally, Robert S. White will join the VitalConnect Board of Directors, bringing significant experience in medical devices and cardiology. Mr. White has more than 30 years’ experience leading early-stage companies and business units of Fortune 500 companies within the medical technology sector.

“We believe the VitalConnect platform will transform the way patient care is delivered by providing physicians with real-time, and more comprehensive, insights into the health of their patients in ways never experienced before,” said Robert “Bob” White, Operating Partner at EW Healthcare Partners. “I look forward to working with the team at VitalConnect to accelerate the company’s growth.”

Founded in 2011, VitalConnect has deployed more than 200,000 patches throughout the world, including care facilities such as Brigham and Women’s, Hackensack Medical Center, Northwell Health, and John Radcliffe Hospital-Oxford University. The VitalPatch allows real-time remote or in-hospital monitoring, allowing physicians to optimize the delivery of care to their patients.

About VitalConnect, Inc.

VitalConnect is a leader in wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. VitalConnect leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms that achieve better health and economic outcomes. VitalConnect’s products are designed for use in a broad range of inpatient and outpatient settings, such as hospital monitoring, post-discharge care, cardiac monitoring and pharmaceutical solutions. For more information:

About EW Healthcare Partners

EW Healthcare Partners is one of the largest and oldest private healthcare investment firms and seeks to make growth equity investments in fast growing commercial-stage healthcare companies in the pharmaceutical, medtech, and technology-enable services sectors in the United States and in Europe. Since its founding in 1985, EW Healthcare Partners has maintained its singular commitment to the healthcare industry and has been a long-term investor in over 150 healthcare companies, ranging across sectors, stages and geographies. The team is comprised of over 20 investment professionals with offices in Houston, New York and London. For more information, see


Media Contacts:
Steve Kelly
VitalConnect, Inc.